We have previously shown that combination of antitumor vaccines harboring TNFSF immunomodulators 4-1BBL, OX40L and the cytokine GM-CSF induce tumor elimination in immunocompetent mice challenged with syngeneic B16 melanoma cells23. This evidence concerns the gene TNFSF4 and melanoma.